Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
Oncology dietitian Annette M. Goldberg discusses what nonalcoholic fatty liver disease (NAFLD) is, what causes it, its link to liver cancer, and the steps you can take to prevent NAFLD.
Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy: Research from the 2022 Gastrointestinal Cancers Symposium
Research from ASCO’s 2022 Gastrointestinal Cancers Symposium will feature 2 abstracts that looked at using immunotherapy to treat advanced liver cancer and biliary tract cancer.
In this podcast, Dr. Andrew Artz and Dr. Jessica Hwang discuss what people with cancer should know about hepatitis B virus, including who should be screened, how to get tested, and how hepatitis B virus can affect people with cancer.
Disparities in Care, Patient-Reported Outcomes, and Blood-Based Testing: Research from the 2020 Gastrointestinal Cancers Symposium
At the 2020 Gastrointestinal Cancers Symposium, research highlights include disparities in care among young adults with colorectal cancer, patient-reported outcomes in liver cancer and colorectal cancer, and a blood-based test to find hard-to-detect cancers.
Organ donation can save lives, including the lives of some people with cancer. Find out how the donation process works and how easy it is to register as a donor.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers.